Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.
Press releases published on August 28, 2025
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
GlobeNewswire
·
August 28, 2025
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” Jain as an independent member of its Board of Directors, subject to …
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 28, 2025
VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced its …
Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date
GlobeNewswire
·
August 28, 2025
Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025 Warrants Must be Exercised Prior to 5:00 p.m. New York City Time on Friday, August 29, 2025 Last Day of Warrant Trading on Nasdaq is Friday, August 29, 2025 Notice of Guaranteed …
Cascade Prodrug Inc. Appoints Industry Veterans Manuel (Manny) Litchman and Andres Gutierrez to Board of Directors
GlobeNewswire
·
August 28, 2025
EUGENE, Ore., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cascade Prodrug, Inc. (“Cascade”), a biotechnology company focused on advancing novel Hypoxia Activated Therapies in oncology, today announced the appointment of Manuel (Manny) Litchman, M.D. and Andres …
Kane Biotech Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 28, 2025
WINNIPEG, Manitoba, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its second quarter 2025 financial results. Second Quarter 2025 Financial Highlights (Comparatives exclude …
NVIDIA Announces Upcoming Event for Financial Community
GlobeNewswire
·
August 28, 2025
SANTA CLARA, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- NVIDIA will present at the following event for the financial community: Goldman Sachs Communacopia + Technology Conference Monday, Sept. 8, 12:25 p.m. Pacific Time Interested parties can listen to the …
IBEX Limited to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on September 11, 2025
GlobeNewswire
·
August 28, 2025
WASHINGTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced it will report fourth quarter and …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
August 28, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
SPS Commerce to Present at Citi's 2025 Global TMT Conference
GlobeNewswire
·
August 28, 2025
MINNEAPOLIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at Citi's 2025 Global TMT Conference on Thursday, September 4, 2025, at 8:10 AM E …
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
GlobeNewswire
·
August 28, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, …
Nutanix to Present at Upcoming Investor Conference
GlobeNewswire
·
August 28, 2025
SAN JOSE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that its management will present at the following upcoming financial community event: Goldman Sachs Communacopia + Technology …
Cardiff Oncology to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will …
Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 28, 2025
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced that …
Key Tronic Celebrates Grand Opening of New Manufacturing Facility in Springdale, Arkansas
GlobeNewswire
·
August 28, 2025
SPRINGDALE, Ark., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation, a leading provider of electronic manufacturing services (EMS), announced the grand opening of its new, state-of-the-art manufacturing facility in Springdale, Arkansas. Company …
89bio to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today …
atai Life Sciences to Participate in September Investor Conferences
GlobeNewswire
·
August 28, 2025
NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in September: Citi 2025 Biopharma Back to School …
Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
GlobeNewswire
·
August 28, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it will host a webinar on Tuesday, …
Nurix Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …